Radiopharm Theranostics Files 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-report
TL;DR
Radiopharm Theranostics filed a 6-K, confirming they'll use Form 20-F for annual reports.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on July 22, 2025, reporting information for the month of July 2025. The company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b). The filing indicates the company will file its annual report under cover of Form 20-F.
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and upcoming filings.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new material financial or operational information.
Key Numbers
- 001-41621 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- Form 6-K (company) — Filing Type
- Form 20-F (company) — Annual Report Cover
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
Which form will Radiopharm Theranostics Limited use for its annual reports?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the company has indicated by check mark that it is not furnishing information under Rule 12g3-2(b).
What is the principal executive office address of Radiopharm Theranostics Limited?
The address of the principal executive office is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of date July 22, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).